Creative Medical Technology Holdings annual return on equity
2022
2023
2024
2025
Creative Medical Technology Holdings Return on Equity (ROE) Growth & History (CELZ)
Creative Medical Technology Holdings's return on equity was −86.53% for fiscal 2025.
View full Creative Medical Technology Holdings company overviewCreative Medical Technology Holdings annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −86.53% | −20.68 pp |
| 2024 | 2024-12-31 | −65.85% | −25.51 pp |
| 2023 | 2023-12-31 | −40.34% | +37.44 pp |
| 2022 | 2022-12-31 | −77.78% | — |
Creative Medical Technology Holdings quarterly return on equity
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −20.48% | −3.91 pp |
| Q1 2026 | 2026-03-31 | −20.63% | +2.12 pp |
| Q4 2025 | 2025-12-31 | −28.81% | −0.06 pp |
| Q3 2025 | 2025-09-30 | −19.90% | −5.22 pp |
| Q2 2025 | 2025-06-30 | −16.57% | +1.93 pp |
| Q1 2025 | 2025-03-31 | −22.75% | −12.10 pp |
| Q4 2024 | 2024-12-31 | −28.75% | −13.79 pp |
| Q3 2024 | 2024-09-30 | −14.68% | −3.42 pp |
| Q2 2024 | 2024-06-30 | −18.50% | −10.78 pp |
| Q1 2024 | 2024-03-31 | −10.64% | −3.79 pp |
| Q4 2023 | 2023-12-31 | −14.96% | +17.81 pp |
| Q3 2023 | 2023-09-30 | −11.26% | −6.91 pp |
| Q2 2023 | 2023-06-30 | −7.72% | +3.34 pp |
| Q1 2023 | 2023-03-31 | −6.86% | +4.95 pp |
| Q4 2022 | 2022-12-31 | −32.77% | +45.89 pp |
| Q3 2022 | 2022-09-30 | −4.35% | — |
| Q2 2022 | 2022-06-30 | −11.06% | — |
| Q1 2022 | 2022-03-31 | −11.80% | — |
| Q4 2021 | 2021-12-31 | −78.65% | — |
Creative Medical Technology Holdings return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, Creative Medical Technology Holdings's return on equity decreased from −77.78% to −86.53%, a change of −8.75 percentage points. The latest reported quarter, Q2 2026, shows −20.48%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Creative Medical Technology Holdings source filings ↗